Application 020918

Type
NDA
Sponsor
NOVO NORDISK

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GLUCAGENGLUCAGON HYDROCHLORIDEINJECTABLE;INJECTIONEQ 1MG BASE/VIALYesYes
002GLUCAGENGLUCAGON HYDROCHLORIDEPOWDER;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020918-001GLUCAGENGLUCAGON HYDROCHLORIDEEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22
N020918-002GLUCAGENGLUCAGON HYDROCHLORIDEEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 58 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-18 06:07:402026-07N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22caaa826d4ba7…
2026-08-18 06:07:402026-07N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22011fe1cb6892…
2026-02-19 14:30 UTC2026-02N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-2231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-226a471c1ec25d…
2025-08-23 18:47 UTC2025-08N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-2203ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-222680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-225bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N020918-001GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-22d06236e962d9…
2024-10-29 15:01 UTC2024-10N020918-002GLUCAGENEQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**POWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020918-001GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUSRLD1998-06-2279d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N020918-002GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD1998-06-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020918-001GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUSRLD, RS1998-06-22301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N020918-002GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD, RS1998-06-22301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020918-001GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUSRLD, RS1998-06-221e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N020918-002GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD, RS1998-06-221e350fbaab3a…
2024-05-31 18:47 UTC2024-05N020918-001GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUSRLD, RS1998-06-228072bd15b7f6…
2024-05-31 18:47 UTC2024-05N020918-002GLUCAGENEQ 1MG BASE/VIALPOWDER / INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUSRLD, RS1998-06-228072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-225c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-225d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-224b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-2274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-22bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-22782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-2287673890dc5c…
2021-03-12 10:30 UTC2021-03N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11N020918-001GLUCAGENEQ 1MG BASE/VIALINJECTABLE / INJECTIONRLD, RS1998-06-22c0c555d07b60…

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 15 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0169-7065GlucaGen HypoKitglucagon hydrochlorideNovo NordiskNDACurrent
0169-7065GlucaGen HypoKitglucagon hydrochlorideNovo NordiskNDACurrent
0169-7065GlucaGen HypoKitglucagon hydrochlorideNovo NordiskNDACurrent
0169-7065GlucaGen HypoKitglucagon hydrochlorideNovo NordiskNDACurrent
0169-7065GlucaGen HypoKitglucagon hydrochlorideNovo NordiskNDACurrent
0597-0053GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0053GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0053GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0053GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0053GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0260GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0260GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0260GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0260GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent
0597-0260GlucaGenglucagon hydrochlorideBoehringer Ingelheim Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
68169SUPPL2021-07-23
68144SUPPL2021-07-22
66764SUPPL2021-03-12
66761SUPPL2021-03-12
64589SUPPL2020-09-17
54866SUPPL2018-07-09
53763SUPPL2018-04-20
53737SUPPL2018-04-19
13735SUPPL2015-12-15
3746SUPPL2015-12-15
3745SUPPL2014-03-19
3744SUPPL2013-04-30
26190SUPPL2012-01-17
13734SUPPL2012-01-06
35640SUPPL2010-12-22
3743SUPPL2010-12-21
41811SUPPL2007-07-20
41810SUPPL2007-07-20
35639SUPPL2005-11-18
26189SUPPL2005-11-18
41809ORIG2005-06-23
13733SUPPL2004-12-29
3742SUPPL2004-12-29
35638SUPPL2004-04-05
26188SUPPL2004-03-02
3741SUPPL2002-07-11
26187ORIG1998-06-22
13732ORIG1998-06-22